NASDAQ
No price data available for this timeframe.
Axsome Therapeutics, Inc. (AXSM) has a current ratio of 1.55x as of Monday, May 25, 2026. This represents a 48.32% decrease compared to its 12-month average of 3.01x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.